アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
A synthetic peptide corresponding to residues in Human KIF22.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our Abpromise guarantee covers the use of ab108535 in the following tested applications.
|WB||1/1000 - 1/10000. Predicted molecular weight: 73 kDa.|
ab108535 has not yet been referenced specifically in any publications.